Literature DB >> 25757814

Ovarian Suspension With Adjustable Sutures: An Easy and Helpful Technique for Facilitating Laparoendoscopic Single-Site Gynecologic Surgery.

Kuo-Hu Chen1, Li-Ru Chen2, Kok-Min Seow3.   

Abstract

STUDY
OBJECTIVE: To describe a method of ovarian suspension with adjustable sutures (OSAS) for facilitating laparoendoscopic single-site gynecologic surgery (LESS) and to investigate the effect of OSAS on LESS.
DESIGN: Prospective cohort study (Canadian Task Force classification: II-2).
SETTING: University teaching hospital. PATIENTS: One hundred seventy-eight patients with benign 5- to 15-cm cystic ovarian tumors who underwent LESS with OSAS (suspension group, n = 90) and without OSAS (control group, n = 88).
INTERVENTIONS: For patients who underwent OSAS (suspension group), 1 end of double-head straight needles with a polypropylene suture was inserted into the pelvic cavity through the abdominal skin to penetrate the cyst or ovarian parenchyma and puncture outside the abdominal skin. After cutting off the needles, both sides of the remaining suture were held together by a clamp, without knotting, so that the manipulator could "lift," "loosen," or "fix" the stitches to adjust the tension.
MEASUREMENTS AND MAIN RESULTS: The average time to create OSAS was 2.9 min. For the suspension and control groups, the average blood loss was 81.4 and 131.8 mL (p < .001), and the operative time was 42.0 and 61.3 min (p < .001), respectively. There were no significant differences in the incidence of complications (5.6% vs 9.1%; p = .365), but there were significant differences in conversions to standard non-single-site laparoscopy (5.6% vs 15.9%; p = .025) and laparotomy (1.1% vs 6.8%; p = .040). Logistic regression analysis revealed that the ratios of conversion to standard non-single-site laparoscopy (odds ratio [OR], 0.126; 95% confidence interval [CI], 0.311-0.508) and laparotomy (OR, 0.032; 95% CI, 0.002-0.479) were much lower in the suspension group; the risk of complications was comparable (OR, 0.346; 95% CI, 0.085-1.403).
CONCLUSION: OSAS is an easy, safe, and feasible method that offers advantages during LESS. Although routine use of OSAS is not necessary, OSAS can be considered during LESS to facilitate the surgery.
Copyright © 2015 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LESS; Laparoendoscopic single-site surgery; OSAS; Ovarian suspension with adjustable sutures; SILS; Single incision laparoscopic surgery

Mesh:

Year:  2015        PMID: 25757814     DOI: 10.1016/j.jmig.2015.02.018

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  4 in total

1.  Phase II clinical experience and long-term follow-up using the next-generation single-incision platform FMX314.

Authors:  Martin Berducci; Hans F Fuchs; Pablo Omelanczuk; Ryan C Broderick; Cristina R Harnsberger; Joshua Langert; Jorge Nefa; Pablo Jaureguiberry; Pablo Gomez; Laura Miranda; Garth R Jacobsen; Bryan J Sandler; Santiago Horgan
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

2.  Ovarian suspension loop: an assembled device for ovarian lifting and immobilization during laparoscopic cystectomy

Authors:  Kobra Tahermanesh; Mansoureh Gorginzadeh; Soheil Hanjani; Roya Shahriyari; Abbas Fazel Anvari-Yazdi; Hamidreza Kelarestaghi; Ibrahim Alkatout; Leila Allahqoli
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-06-01

3.  True single-port cholecystectomy with ICG cholangiography through a single 15-mm trocar using the new surgical platform "symphonX": first human case study with a commercially available device.

Authors:  Rabi R Datta; Georg Dieplinger; Roger Wahba; Robert Kleinert; Michael Thomas; Florian Gebauer; Lars Schiffmann; Dirk L Stippel; Christiane J Bruns; Hans F Fuchs
Journal:  Surg Endosc       Date:  2019-10-28       Impact factor: 4.584

4.  Safety and efficacy of two techniques of temporary ovarian suspension to the anterior abdominal wall after operative laparoscopy.

Authors:  Omar M Abuzeid; John Hebert; Mohammad Ashraf; Mohamed Mitwally; Michael P Diamond; Mostafa I Abuzeid
Journal:  Facts Views Vis Obgyn       Date:  2018-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.